Agilent Technologies Inc Stock Price, News & Analysis

TORM plc (TRMD) has announced the completion of two significant corporate actions following approval from the High Court of Justice in England and Wales. The company executed a USD 180 million capital reduction from its share premium account and cancelled 493,371 A-shares previously held as Treasury Shares. Following these actions, TORM's share capital now stands at USD 979,411.95, consisting of 97,941,193 A-shares, one B-share, and one C-share, all with a nominal value of USD 0.01 each. The capital reduction does not involve any distribution or payment of capital and does not change the nominal value of shares. These corporate actions were previously approved by shareholders at the Annual General Meeting held on April 16, 2025.

Agilent Technologies (NYSE: A) has declared a quarterly dividend of 24.8 cents per share of common stock. The dividend will be paid on July 23, 2025, to shareholders of record as of July 1, 2025. The company notes that future dividend amounts and timing will be subject to board approval.

Agilent Technologies (NYSE: A) has announced two significant additions to its Board of Directors: Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, effective May 21, 2025. Soriot brings extensive pharmaceutical industry experience as AstraZeneca's CEO since 2012, while Gawlik Brown contributes substantial financial and strategic expertise from her roles at Perrigo Company and Amgen. The appointments coincide with Agilent's three-year Ignite Transformation initiative.

Simultaneously, Heidi Kunz is retiring from the Board after more than 20 years of service, having joined at the company's inception in 2000. Agilent, which generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide, continues its commitment to balanced Board refreshment.

Agilent Technologies (NYSE: A) has announced that its new Infinity III LC Series liquid chromatography instruments have received the My Green Lab ACT Ecolabel 2.0 certification, becoming the first Agilent instruments to achieve this distinction. The series features energy-efficient workflows, automated tasks, and optimized solvent management to support sustainable laboratory operations. Notable innovations include a modular design allowing Infinity II LC upgrades and the industry-first capability to provide CO2 footprint information to customers. The certification reflects Agilent's commitment to sustainable scientific innovation, helping laboratories reduce their ecological footprint while maintaining high-quality results. The My Green Lab ACT Ecolabel 2.0 represents an evolution in lab product sustainability assessment, using standardized, science-based methods to evaluate environmental impact.

TORM plc (NASDAQ: TRMD) has announced a capital increase through the issuance of 151,581 A-shares at a nominal value of USD 1,515.81. This increase results from the exercise of Restricted Share Units as part of the company's incentive program. The new shares were subscribed for in cash at DKK 0.08 per A-share.

Following the capital increase, TORM's total share capital now stands at USD 984,345.66, consisting of 98,434,564 A-shares, one B-share, and one C-share, each with a nominal value of USD 0.01. The A-shares carry a total of 98,434,564 votes, while the B and C shares have specific voting rights. The new shares are expected to be listed on Nasdaq Copenhagen soon.

TORM plc (NASDAQ: TRMD) has reported an insider transaction involving CEO and Executive Director Jacob Balslev Meldgaard. The executive exercised 33,559 restricted share units at a price of DKK 0.08 per share, totaling DKK 2,684.72. The transaction was executed on May 19, 2025, outside a trading venue.

TORM is a leading carrier of refined oil products, operating a fleet of product tanker vessels with a focus on safety and environmental responsibility. The company, founded in 1889, has its shares listed on both Nasdaq Copenhagen and Nasdaq New York.

Agilent Technologies (NYSE: A) announced that CEO Padraig McDonnell and CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for June 4, 2025, at 10:30 a.m. Eastern in New York City. Investors and interested parties can access a live audio webcast and replay of the presentation through the Agilent Investor Relations website.

Crawford & Company (NYSE: CRD-A and CRD-B) has announced its quarterly dividend declaration following its regular board meeting on May 7, 2025. The company will distribute a dividend of $0.07 per share for both Class A and Class B Common Stock. The dividend will be paid on June 6, 2025, to shareholders who are on record as of the market close on May 23, 2025.

Summary not available.